GlassScriptPhysician profile
Candi L Calvert
NPI 1376937979
$1,325.11
in general payments reported to CMS, 2019-2025
12 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $20.65 · 2023: $246 · 2024: $462 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $222.33 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $181.50 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $175.25 | 2021-2024 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $168.43 | 2021-2025 | Amvuttra |
| Abbott Laboratories | $153.77 | 2023-2025 | Cardiomems |
| Amgen INC. | $127.76 | 2021-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.01 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $53.56 | 2024 | Wegovy |
| Medtronic, INC. | $46.25 | 2021 | |
| Merck Sharp & Dohme LLC | $32.81 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.22 | 2024 | Lifevest |
| Lilly USA, LLC | $19.22 | 2024 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candi Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.